245 related articles for article (PubMed ID: 26192403)
21. Isolation and cellular properties of mesenchymal cells derived from the decidua of human term placenta.
Kanematsu D; Shofuda T; Yamamoto A; Ban C; Ueda T; Yamasaki M; Kanemura Y
Differentiation; 2011 Sep; 82(2):77-88. PubMed ID: 21684674
[TBL] [Abstract][Full Text] [Related]
22. Transplantation-potential-related biological properties of decidua basalis mesenchymal stem cells from maternal human term placenta.
Lu G; Zhu S; Ke Y; Jiang X; Zhang S
Cell Tissue Res; 2013 May; 352(2):301-12. PubMed ID: 23397423
[TBL] [Abstract][Full Text] [Related]
23. Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease.
Ringdén O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
Stem Cells; 2013 Mar; 31(3):592-601. PubMed ID: 23307526
[TBL] [Abstract][Full Text] [Related]
24. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes.
Lee HJ; Jung J; Cho KJ; Lee CK; Hwang SG; Kim GJ
Differentiation; 2012 Oct; 84(3):223-31. PubMed ID: 22885322
[TBL] [Abstract][Full Text] [Related]
25. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
26. Ectopic Bone Formation by Mesenchymal Stem Cells Derived from Human Term Placenta and the Decidua.
Kusuma GD; Menicanin D; Gronthos S; Manuelpillai U; Abumaree MH; Pertile MD; Brennecke SP; Kalionis B
PLoS One; 2015; 10(10):e0141246. PubMed ID: 26484666
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.
Kuçi Z; Bönig H; Kreyenberg H; Bunos M; Jauch A; Janssen JW; Škifić M; Michel K; Eising B; Lucchini G; Bakhtiar S; Greil J; Lang P; Basu O; von Luettichau I; Schulz A; Sykora KW; Jarisch A; Soerensen J; Salzmann-Manrique E; Seifried E; Klingebiel T; Bader P; Kuçi S
Haematologica; 2016 Aug; 101(8):985-94. PubMed ID: 27175026
[TBL] [Abstract][Full Text] [Related]
28. Does the maternal age affect the mesenchymal stem cell markers and gene expression in the human placenta? What is the evidence?
Alrefaei GI; Al-Karim S; Ayuob NN; Ali SS
Tissue Cell; 2015 Aug; 47(4):406-19. PubMed ID: 26067657
[TBL] [Abstract][Full Text] [Related]
29. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
30. Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells.
Barlow S; Brooke G; Chatterjee K; Price G; Pelekanos R; Rossetti T; Doody M; Venter D; Pain S; Gilshenan K; Atkinson K
Stem Cells Dev; 2008 Dec; 17(6):1095-107. PubMed ID: 19006451
[TBL] [Abstract][Full Text] [Related]
31. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.
Nystedt J; Anderson H; Tikkanen J; Pietilä M; Hirvonen T; Takalo R; Heiskanen A; Satomaa T; Natunen S; Lehtonen S; Hakkarainen T; Korhonen M; Laitinen S; Valmu L; Lehenkari P
Stem Cells; 2013 Feb; 31(2):317-26. PubMed ID: 23132820
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of response.
Calkoen FG; Jol-van der Zijde CM; Mearin ML; Schweizer JJ; Jansen-Hoogendijk AM; Roelofs H; van Halteren AG; Egeler RM; van Tol MJ; Ball LM
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1590-9. PubMed ID: 23994245
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.
de Lima KA; de Oliveira GL; Yaochite JN; Pinheiro DG; de Azevedo JT; Silva WA; Covas DT; Couri CE; Simões BP; Voltarelli JC; Oliveira MC; Malmegrim KC
Stem Cell Res Ther; 2016 Jul; 7(1):92. PubMed ID: 27406064
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of telomere length, telomerase and reverse transcriptase activity in human dental stem cells.
Jeon BG; Kang EJ; Kumar BM; Maeng GH; Ock SA; Kwack DO; Park BW; Rho GJ
Cell Transplant; 2011; 20(11-12):1693-705. PubMed ID: 21396170
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stromal cell secretomes are modulated by suspension time, delivery vehicle, passage through catheter, and exposure to adjuvants.
Parsha K; Mir O; Satani N; Yang B; Guerrero W; Mei Z; Cai C; Chen PR; Gee A; Hanley PJ; Aronowski J; Savitz SI
Cytotherapy; 2017 Jan; 19(1):36-46. PubMed ID: 27856228
[TBL] [Abstract][Full Text] [Related]
36. Maxillofacial-derived stem cells regenerate critical mandibular bone defect.
Steinhardt Y; Aslan H; Regev E; Zilberman Y; Kallai I; Gazit D; Gazit Z
Tissue Eng Part A; 2008 Nov; 14(11):1763-73. PubMed ID: 18636943
[TBL] [Abstract][Full Text] [Related]
37. Remestemcel-L for the treatment of graft versus host disease.
Locatelli F; Algeri M; Trevisan V; Bertaina A
Expert Rev Clin Immunol; 2017 Jan; 13(1):43-56. PubMed ID: 27399600
[TBL] [Abstract][Full Text] [Related]
38. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.
Nekanti U; Rao VB; Bahirvani AG; Jan M; Totey S; Ta M
Stem Cells Dev; 2010 Jan; 19(1):117-30. PubMed ID: 19619003
[TBL] [Abstract][Full Text] [Related]
39. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
